filmov
tv
Current treatment options for NSCLC without driver mutations
Показать описание
Luis Raez, MD, FACP, FCCP, Memorial Healthcare System, Pembroke Pines, FL, discusses approaches to treating non-small cell lung cancer (NSCLC) without targetable mutations. Trials such as the KEYNOTE-189 (NCT02578680) and IMpower150 (NCT02366143) studies have demonstrated the efficacy of pembrolizumab or atezolizumab plus chemotherapy, respectively. Tremelimumab plus durvalumab, which was assessed in the Phase III POSEIDON study (NCT03164616), and cemiplimab have additionally given clinicians more choices in potential treatment regimens. This interview took place at the Practical Recommendations in Immuno and Molecular Oncology (PRIMO) 2023 Congress in Honolulu, HI.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
0:02:21
Current treatment options for NSCLC without driver mutations
0:02:46
Current treatment options for squamous cell lung cancer
0:03:30
Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)
0:01:33
Dr. Giaccone on Treatment Options in NSCLC
0:20:24
Targeted treatment with EGFR TKIs: Front line options
0:02:53
The current treatment landscape for SCLC
0:03:35
GRACE Targeted Therapies Lung Cancer 2021 - Current Treatment Options for EGFR Fusions e.g. RAD 51
0:23:38
Squamous Lung Cancer - Currently Available Treatment Options
0:04:42
KRAS-Mutant NSCLC: Current Systemic Treatment Options
0:51:59
Facilitating Progress in the Treatment of SCLC
0:51:42
Updates in the Management of Lung Cancer
0:20:58
How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi
0:02:07
Increasing treatment options for NSCLC
0:02:46
Treatment differences for SCLC vs. NSCLC that turns into small cell? - Living Room Highlights
0:09:18
GRACECast - Treatment Options for Metastatic NSCLC
0:08:02
Lung Cancer Video Library - Das - Targeted Therapies NSCLC PDL1 Expression Leading Treatment Options
0:11:03
Treatment for Patients with Advanced NSCLC - Leading Developments & Current Questions in Lung Ca...
0:02:29
Understanding Lung Cancer Survival Rate
0:00:20
I was Diagnosed with Stage 4 Lung Cancer!
0:00:58
Exploring Treatment Options for Patients with ALK-Mutated Lung Cancer
0:07:35
Treatment for Patients with EGFR+ NSCLC - Leading Developments & Current Questions in Lung Cance...
0:20:32
GRACE Targeted Therapies Lung Cancer 2021 - ROS Current Therapies, Emerging Treatment Options
0:10:06
Lung cancer: what are the newest treatment options available? - Online interview
0:06:03
Lung Cancer Video Library - Gubens - Targeted Therapies in NSCLC - Treatment Options for Low PDL1
Комментарии